Fabio
4.5 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Relates to prescribing an opioid antagonist with a patient's first opioid prescription each year | Provides that with the first opioid prescription of each year for use in a setting other than a general hospital or nursing home under article twenty-eight of this chapter or facility under article thirty-one of the mental hygiene law, or when a practitioner is prescribing a controlled substance to a patient under the care of hospice, the prescriber shall prescribe an opioid antagonist when any of the following risk factors are present: a history of substance abuse disorder; high dose or cumulative prescriptions that result in 90 morphine milligram equivalents or higher per day; concurrent use of opioids and benzodiazepine or nonbenzodiazepine sedative hypnotics. | us/states/ny | New York Legislature | 2021-2022 | A 336 | New York A 336 (2021-2022) |
|
enacted |
|
2 | 17 | 2 | 2021-01-06 | 2021-12-30 | openstates | ocd-bill/90779e16-6813-474d-bbef-ec5827ebf5f9 | http://www.nysenate.gov/legislation/bills/2021/A336 | 72f9abe3813a39966d88532767012f55f01e00b070c4307b66f0fee0a1de93d5 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
New York A 336 (2021-2022) — Relates to prescribing an opioid antagonist with a patient's first opioid prescription each year
Provides that with the first opioid prescription of each year for use in a setting other than a general hospital or nursing home under article twenty-eight of this chapter or facility under article thirty-one of the mental hygiene law, or when a practitioner is prescribing a controlled substance to a patient under the care of hospice, the prescriber shall prescribe an opioid antagonist when any of the following risk factors are present: a history of substance abuse disorder; high dose or cumulative prescriptions that result in 90 morphine milligram equivalents or higher per day; concurrent use of opioids and benzodiazepine or nonbenzodiazepine sedative hypnotics.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
Votes
- Assembly Vote — 144–3 (pass) · lower
- Floor Vote - Version: A — 51–12 (pass) · upper
Sponsors
- BRAUNSTEIN — primary (person)
- AUBRY — cosponsor (person)
- BARRON — cosponsor (person)
- CYMBROWITZ — cosponsor (person)
- DINOWITZ — cosponsor (person)
- FERNANDEZ — cosponsor (person)
- HEVESI — cosponsor (person)
- HUNTER — cosponsor (person)
- JOYNER — cosponsor (person)
- MCDONALD — cosponsor (person)
- OTIS — cosponsor (person)
- PERRY — cosponsor (person)
- RAMOS — cosponsor (person)
- ROSENTHAL L — cosponsor (person)
- ROZIC — cosponsor (person)
- STECK — cosponsor (person)
- STERN — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2021-01-06 REFERRED TO HEALTH
referral-committee - 2021-02-09 REPORTED REFERRED TO WAYS AND MEANS
referral-committee - 2021-04-19 AMEND AND RECOMMIT TO WAYS AND MEANS
amendment-passage, referral-committee - 2021-04-19 PRINT NUMBER 336A
amendment-passage - 2021-05-19 REPORTED REFERRED TO RULES
referral-committee - 2021-05-24 REPORTED
- 2021-05-24 RULES REPORT CAL.68
- 2021-05-24 ORDERED TO THIRD READING RULES CAL.68
- 2021-05-24 PASSED ASSEMBLY
passage - 2021-05-24 DELIVERED TO SENATE
- 2021-05-24 REFERRED TO FINANCE
referral-committee - 2021-06-03 SUBSTITUTED FOR S2966A
- 2021-06-03 3RD READING CAL.904
- 2021-06-03 PASSED SENATE
passage - 2021-06-03 RETURNED TO ASSEMBLY
- 2021-12-17 DELIVERED TO GOVERNOR
executive-receipt - 2021-12-30 SIGNED CHAP.803
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/90779e16-6813-474d-bbef-ec5827ebf5f9. Confidence: reported (aggregated from official New York legislature records).